Published Erratum
doi: 10.1093/ofid/ofag066.
eCollection 2026 Feb.
Correction to: Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions
- PMID: 41716679
- PMCID: PMC12915509
- DOI: 10.1093/ofid/ofag066
Item in Clipboard
Published Erratum
Correction to: Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions
Open Forum Infect Dis.
.
Abstract
[This corrects the article DOI: 10.1093/ofid/ofaf368.].
© The Author(s) 2026. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Erratum for
-
Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.Open Forum Infect Dis. 2025 Jul 3;12(7):ofaf368. doi: 10.1093/ofid/ofaf368. eCollection 2025 Jul. Open Forum Infect Dis. 2025. PMID: 40735332 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
